Building Fit-for-Purpose Oncology Real-World Evidence in Japan, Upcoming Webinar Hosted by Xtalks

In this free webinar, learn how real-world evidence (RWE) can support oncology evidence strategies in Japan. The featured speakers will discuss how Japanese data sources differ from those in other major markets, including the role of electronic health record-derived real-world data. Attendees will also explore data quality, completeness and practical considerations for global teams developing or expanding RWE programs in Japan.

TORONTO, Sept. 30, 2026 /PRNewswire/ -- Japan is one of the world's largest oncology markets and an increasingly important part of global real-world evidence (RWE) strategies. Yet oncology RWE in Japan has developed differently than in the US and Europe, shaped by distinct data sources, care delivery models and evolving sponsor needs across clinical development, medical affairs and evidence planning.

As sponsors expand their global evidence programs, Japanese data has become central to a representative RWE strategy. In this panel discussion, experts from across the industry will discuss how global biopharma teams can succeed with Japan RWE programs. Topics will include:

• How oncology RWE adoption in Japan compares to other major markets and what's driving recent momentum
• What distinguishes fit-for-purpose Japanese EHR-derived real-world data (RWD) from claims or registry datasets
• Industry perspectives on data quality, completeness and relevance for real-world research
• Practical considerations for global teams partnering with local experts on Japan evidence strategies

Register for this webinar to learn how RWE can support fit-for-purpose oncology evidence strategies in Japan.

Join Eri Tajima, Country Lead, Japan, Flatiron Health; Hideaki Bando, Head, Division of Drug Development Promotion, Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Japan; Yasushi Goto, Chief, Department of Thoracic Oncology, National Cancer Center Hospital; and Dina Oksen, Director, Real-World Data & Analytics Lead, Asia R&D, GSK, for the live webinar on Thursday, October 15, 2026, at 4 pm JST (9am CET / EU-Central).

For more information, or to register for this event, visit Building Fit-for-Purpose Oncology Real-World Evidence in Japan.

ABOUT XTALKS

Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector.

Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next.

To learn more about Xtalks, visit www.xtalks.com
For information about working with Xtalks to host your webinar, visit https://xtalks.com/partner-with-us/

Contact:
Soumya Shashikumar
Tel: +1 (416) 977-6555 x371
Email: [email protected]

SOURCE Xtalks